FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain
“This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding,” says Cybin’s chief clinical officer.